Study guide
1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness
C-OBE Obstetric Emergencies Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems
1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness
2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics
2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing
3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion
3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)
4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features
4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia
5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy
5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management
6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean
6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)
7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States
7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive
8 Chapter 8: Acute Intrapartum Delivery Emergencies
8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols
9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma
9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage
10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections
10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections
11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies
11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)
12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies
12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration
13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications
13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol
14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity
14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies
1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness
Key Takeaways Explain This Topic AI
The Alliance for Innovation on Maternal Health (AIM) safety bundle structure standardizes maternal critical care across five domains: Readiness (every unit), Recognition and Prevention (every patient), Response (every emergency), Reporting and Systems Learning (every unit and case), and — added in 2022 — Respectful, Equitable, and Supportive Care (every patient).
Under the Severe Hypertension in Pregnancy bundle, first-line antihypertensive therapy (IV labetalol, IV hydralazine, or oral immediate-release nifedipine) must be administered within a mandatory benchmark of 30 to 60 minutes from the second confirmed severe-range blood pressure reading (SBP >=160 or DBP >=110 mmHg).
The AIM Obstetric Hemorrhage bundle mandates routine Quantitative Blood Loss (QBL) measurement using gravimetric (weight-based) and calibrated volumetric tools rather than visual estimation, triggering staged interventions at Stage 1 (QBL >=500 mL vaginal or >=1,000 mL cesarean with normal vitals), Stage 2 (QBL 1,000-1,499 mL), and Stage 3 (QBL >=1,500 mL or MTP activation).
The Maternal Sepsis bundle operationalizes the Sepsis 1-Hour Bundle in pregnancy: obtain blood cultures prior to antibiotics, check serum lactate, initiate broad-spectrum IV antibiotics within 1 hour, administer 30 mL/kg crystalloid bolus for hypotension or lactate >=4.0 mmol/L, and initiate norepinephrine for refractory septic shock.
High-fidelity in-situ simulation drills, standardized emergency supply carts (hemorrhage carts, eclampsia boxes, difficult airway carts), and multidisciplinary post-event debriefs are mandatory institutional readiness components that directly reduce preventable maternal mortality.
Last updated: August 2026
Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness
The Alliance for Innovation on Maternal Health (AIM) is a national, data-driven maternal safety initiative developed by ACOG, SMFM, AWHONN, and federal partners. AIM safety bundles synthesize evidence-based clinical practices into standardized, operational toolkits designed to eliminate preventable maternal mortality and severe maternal morbidity (SMM).
1. The Five-Domain AIM Structural Framework
Every AIM safety bundle is organized around a standardized set of domains ensuring that high-reliability clinical systems are established before, during, and after an obstetric crisis. AIM bundles were originally built on four domains (the "4 R's"); in 2022 AIM added a fifth domain, Respectful, Equitable, and Supportive Care , and integrated health-equity considerations into the elements of every other domain. Current bundles — including the Obstetric Hemorrhage, Severe Hypertension, Sepsis, and Cardiac Conditions bundles — are all published in this five-domain structure, so a candidate who memorizes only the legacy four domains will miss the equity domain entirely: +---------------------------------------------------------------------------------------------------+
- | THE AIM FIVE-DOMAIN SAFETY BUNDLE FRAMEWORK |
- | |
- | 1. READINESS (Every Unit): |
- | • Standardized emergency supply carts, pre-packaged medication kits, and rapid diagnostic |
- | access available on every labor, antepartum, and postpartum unit. |
- | • Multidisciplinary team training, clinical simulation drills, and role-definition cards. |
- | |
- | 2. RECOGNITION & PREVENTION (Every Patient): |
- | • Standardized risk assessment completed on admission, during labor, and postpartum. |
- | • Objective measurement tools (e.g., Quantitative Blood Loss [QBL], continuous MEWT triggers) |
- | replacing subjective clinical guesswork. |
- | |
- | 3. RESPONSE (Every Emergency): |
- | • Standardized, stage-based clinical escalation pathways and emergency algorithms. |
- | • Interdisciplinary Obstetric Rapid Response Teams (OB-RRT) / Code Crimson / Code OB. |
- | • Dedicated bedside emergency checklists to prevent omission of critical interventions. |
- | |
- | 4. REPORTING & SYSTEMS LEARNING (Every Unit / Every Case): |
- | • Routine, blame-free multidisciplinary clinical debriefs following every emergency event. |
- | • Comprehensive multidisciplinary case review of all severe maternal morbidity (SMM) events. |
- | • Tracking unit-level structure, process, and outcome quality improvement metrics. |
- | |
- | 5. RESPECTFUL, EQUITABLE & SUPPORTIVE CARE (Every Patient / Every Unit) — added 2022: |
- | • Best practices for respectful, equitable, and supportive care delivered to every patient, |
- | including shared decision-making and support for the patient's chosen support persons. |
- | • Unit-level education on implicit bias, structural racism, and trauma-informed care. |
- | • Stratification of every quality metric by race, ethnicity, language, and payer so that |
- | inequities in QBL documentation, treatment timeliness, and outcomes become visible. |
- +---------------------------------------------------------------------------------------------------+
- 2. Core AIM Clinical Bundles & Operational Protocols
- A. Obstetric Hemorrhage Bundle
Readiness:
Dedicated Postpartum Hemorrhage Cart on unit (stocked with intrauterine balloon tamponade catheters [Bakri], vacuum-induced hemorrhage control systems [Jada], B-Lynch suture needles, sterile weighted speculums, long instruments, and surgical packs).
Hemorrhage Medication Kit in unit Pyxis/Omnicell for instant access (Oxytocin, Methylergonovine, 15-methyl PGF2-alpha [Carboprost], Misoprostol, Tranexamic Acid [TXA]).
Established Massive Transfusion Protocol (MTP) delivering balanced 1:1:1 ratios of Packed Red Blood Cells (PRBCs), Fresh Frozen Plasma (FFP), and Platelets, with immediate uncrossmatched O-negative / O-positive PRBC availability.
Recognition (Quantitative Blood Loss - QBL):
Visual estimation of blood loss is notoriously inaccurate, underestimating large losses by 30% to 50% and delaying resuscitation. AIM mandates routine QBL measurement for all deliveries:
Gravimetric method: Weighing all blood-soaked sponges, pads, and lap sponges using gram scales and subtracting known dry weight ( 1 gram = 1 mL of blood 1\text{ gram} = 1\text{ mL of blood} 1 gram = 1 mL of blood ). Direct suction canisters and calibrated under-buttocks drapes measure fluid volume with amniotic fluid subtraction.
Response: Staged Clinical Action Pathway:
Hemorrhage Stage Clinical Triggers & Blood Loss Definition Standardized Clinical Action Plan
Stage 1 QBL >=500 mL (vaginal) or >=1,000 mL (cesarean) with normal maternal vital signs and normal lab parameters. • Establish large-bore IV access (16- or 18-gauge).; • Fundal massage and express clots.; • Increase mainline Oxytocin (500 mL/hr of 20–40 units/1,000 mL solution).; • Administer secondary uterotonic: Methylergonovine 0.2 mg IM (if not hypertensive) or Carboprost 250 mcg IM (if not asthmatic) or Misoprostol 800–1,000 mcg PR/SL.; • Administer Tranexamic Acid (TXA) 1 g IV over 10 minutes within 3 hours of birth.; • Insert Foley catheter with urometer to monitor urine output.; • Type and Screen active.
Stage 2 QBL 1,000–1,499 mL with continued active bleeding OR abnormal vital signs (tachycardia, tachypnea, hypotension, SI >=0.9). • ACTIVATE OB RAPID RESPONSE TEAM / HEMORRHAGE TEAM. ; • Bring Hemorrhage Cart to bedside.; • Obtain second large-bore IV; draw STAT labs (CBC, Coags, Fibrinogen, POC Blood Gas/Lactate, Type & Cross 2–4 units PRBCs).; • Move to operating room if bleeding uncontained.; • Deploy intrauterine tamponade balloon (Bakri) or vacuum device (Jada) or perform surgical exploration for lacerations/retained tissue.; • Warm patient; apply forced-air warming blanket.
Stage 3 QBL >=1,500 mL , continued refractory bleeding, abnormal vitals / shock, or transfusion of >=2 units PRBCs. • ACTIVATE MASSIVE TRANSFUSION PROTOCOL (MTP). ; • Transfuse uncrossmatched PRBCs, FFP, and Platelets in a strict 1:1:1 ratio .; • Urgent surgical interventions: B-Lynch compression sutures, bilateral uterine artery ligation (O'Leary stitches), hypogastric artery ligation, or emergent peripartum hysterectomy .; • Involve Interventional Radiology for uterine artery embolization if stable.; • Transfer to ICU setting postoperatively.
B. Severe Hypertension in Pregnancy Bundle +---------------------------------------------------------------------------------------------------+
- | CRITICAL 30–60 MINUTE SEVERE HYPERTENSION PROTOCOL |
- | |
- | • DEFINITION: Persistent severe-range blood pressure defined as: |
- | Systolic BP >=160 mmHg OR Diastolic BP >=110 mmHg, confirmed on repeat measurement |
- | within 15 minutes. |
- | • MANDATORY TIME BENCHMARK: First-line antihypertensive therapy MUST be administered as soon |
- | as possible, and STRICTLY WITHIN 30 TO 60 MINUTES of confirmation! |
- | • CLINICAL GOAL: Rapid reduction of blood pressure to safe range (SBP 140–150 / DBP 90–100 mmHg) |
- | to prevent fatal maternal hemorrhagic stroke, intracranial hemorrhage, and placental abruption.|
- +---------------------------------------------------------------------------------------------------+
Standardized First-Line Antihypertensive Algorithms +---------------------------------------------------------------------------------------------------+
- | REGIMEN 1: IV LABETALOL (Avoid in active asthma, severe bradycardia, or decompensated CHF) |
- | • Step 1: 20 mg IV push over 2 minutes. Recheck BP in 10 minutes. |
- | • Step 2: If BP remains severe, administer 40 mg IV push over 2 minutes. Recheck in 10 minutes. |
- | • Step 3: If BP remains severe, administer 80 mg IV push over 2 minutes. Recheck in 10 minutes. |
- | • Step 4: If BP remains severe, switch to IV Hydralazine 10 mg IV push. Consult critical care. |
- | (Maximum cumulative IV labetalol dose: 220–300 mg). |
- | |
- | REGIMEN 2: IV HYDRALAZINE (Direct arteriolar vasodilator) |
- | • Step 1: 5 mg or 10 mg IV push over 2 minutes. Recheck BP in 20 minutes. |
- | • Step 2: If BP remains severe, administer 10 mg IV push over 2 minutes. Recheck in 20 minutes. |
- | • Step 3: If BP remains severe, administer 20 mg IV labetalol push or switch to labetalol. |
- | |
- | REGIMEN 3: ORAL IMMEDIATE-RELEASE NIFEDIPINE (Preferred if IV access is not yet established) |
- | • Step 1: 10 mg or 20 mg PO (swallowed, NOT bitten or sublingual). Recheck BP in 20 minutes. |
- | • Step 2: If BP remains severe, administer 20 mg PO in 20 minutes. |
- | • Step 3: If BP remains severe, administer 20 mg PO in 20 minutes; obtain IV access for labetalol.|
- +---------------------------------------------------------------------------------------------------+
Seizure Prophylaxis: Concurrently administer Magnesium Sulfate (4–6 g IV loading dose in 100 mL over 15–20 minutes, followed by 1–2 g/hr continuous IV maintenance infusion for 24 hours postpartum) for all patients with severe preeclampsia or eclampsia.
C. Maternal Sepsis Bundle
Pregnancy-associated sepsis accounts for over 12% of maternal deaths and is characterized by rapid progression from occult infection to septic shock and multi-organ dysfunction. +---------------------------------------------------------------------------------------------------+
- | MATERNAL SEPSIS 1-HOUR EMERGENCY BUNDLE |
- | |
- | Upon recognition of suspected maternal sepsis or S.O.S. / MEWT trigger: |
- | 1. MEASURE SERUM LACTATE: Draw STAT point-of-care or laboratory serum lactate. Repeat within |
- | 2 to 4 hours if initially elevated (>2.0 mmol/L). |
- | 2. BLOOD CULTURES BEFORE ANTIBIOTICS: Obtain at least 2 sets of blood cultures (aerobic and |
- | anaerobic) from separate venipuncture sites, along with urine, sputum, or wound cultures. |
- | 3. BROAD-SPECTRUM IV ANTIBIOTICS: Administer empiric broad-spectrum IV antimicrobial therapy |
- | (e.g., Ampicillin + Gentamicin + Clindamycin, or Piperacillin-Tazobactam, or Cefepime + |
- | Vancomycin) STRICTLY WITHIN 1 HOUR OF RECOGNITION. |
- | 4. RAPID FLUID RESUSCITATION: Administer 30 mL/kg of IV crystalloid (Lactated Ringer's) for |
- | hypotension (MAP <65 mmHg or SBP <90 mmHg) or initial serum lactate >=4.0 mmol/L. |
- | 5. VASOPRESSORS: Initiate NOREPINEPHRINE infusion as first-line vasopressor if MAP remains |
- | <65 mmHg despite adequate fluid resuscitation to maintain tissue and placental perfusion. |
- +---------------------------------------------------------------------------------------------------+
- D. Reduction of Perinatal Health Disparities & Equity Bundle
Severe maternal morbidity and mortality disproportionately impact racial and ethnic minority populations. In the United States, Black and American Indian / Alaska Native women are 2 to 3 times more likely to die from pregnancy-related complications than non-Hispanic white women, even after controlling for education, income, and insurance status.
Standardized Clinical Care: Implementation of standardized AIM bundles removes individual clinical subjectivity and unconscious provider bias, ensuring that every patient presenting with severe hypertension, hemorrhage, or sepsis receives identical, protocolized, time-critical care.
Trauma-Informed & Culturally Congruent Care: Universal social determinants of health (SDOH) screening, continuous implicit bias training for all obstetric personnel, and patient-centered communication models that actively listen to and validate patient-reported symptoms.
- 3. High-Fidelity In-Situ Simulation Drills & Emergency Cart Architecture
- Unit Drills & High-Reliability Teams
To ensure rapid execution during real emergencies, units must conduct frequent in-situ interprofessional simulation drills involving obstetricians, maternal-fetal medicine specialists, labor and delivery nurses, anesthesiologists, blood bank technologists, scrub technicians, and neonatologists:
- Postpartum Hemorrhage & MTP Activation Drills
- Severe Hypertension & Eclamptic Seizure Drills
Maternal Cardiac Arrest & Resuscitative Hysterotomy (Perimortem Cesarean Delivery) Drills: Standardizing the 4-minute rule —if maternal return of spontaneous circulation (ROSC) is not achieved within 4 minutes of cardiac arrest, initiate immediate bedside resuscitative hysterotomy at the location of arrest to deliver the fetus by minute 5, relieving aortocaval compression and restoring maternal CPR effectiveness.
Standardized Emergency Cart & Kit Architecture +---------------------------------------------------------------------------------------------------+
- | STANDARDIZED OBSTETRIC EMERGENCY CARTS & KIT TOPOLOGY |
- | |
- | 1. POSTPARTUM HEMORRHAGE CART: |
- | • Shelf 1: Sterile gloves, suture materials (Chromic, Vicryl, #1 PDS, B-Lynch blunt needles). |
- | • Shelf 2: Vaginal retractors, weighted speculum, long needle drivers, sponge forceps. |
- | • Shelf 3: Intrauterine balloons (Bakri) + 60 mL syringes, Jada intrauterine vacuum systems. |
- | • Shelf 4: Calibrated blood collection drapes, surgical packs, abdominal lap sponges. |
- | |
- | 2. SEVERE HYPERTENSION / ECLAMPSIA BOX: |
- | • Labetalol 20 mg/4 mL vials (x4) |
- | • Hydralazine 20 mg/mL vials (x2) |
- | • Immediate-release oral Nifedipine 10 mg capsules (x4) |
- | • Magnesium Sulfate 50% vials & pre-mixed infusion bags (4 g/100 mL and 20 g/500 mL) |
- | • Calcium Gluconate 10% 1 g/10 mL vial (Antidote for magnesium toxicity) |
- | • Bedside Severe Hypertension Escalation Flowsheet |
- | |
- | 3. DIFFICULT OBSTETRIC AIRWAY CART: |
- | • Video Laryngoscope (GlideScope) with hyperangulated blades (sizes 3 and 4) |
- | • Second-generation Supraglottic Airway Devices (LMA Supreme / i-gel) sizes 3, 4, 5 |
- | • Endotracheal Tube Introducers (Bougies), Stylets, ETTs sizes 6.0, 6.5, 7.0 |
- | • Emergency Surgical Cricothyroidotomy Kit (Scalpel-Bougie-Tube technique) |
- +---------------------------------------------------------------------------------------------------+